Chemokine Mechanisms in Chronic Pelvic Pain
CompletedNCT01676857
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to identify biomarkers that can be utilized in the diagnosis of chronic pelvic pain syndrome in men.
Study details
- Official title
- Chemokine Mechanisms in Chronic Pelvic Pain
- Sponsor
- Northwestern University
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Start date
- 2010-05
- Primary completion
- 2018-01-31
- Sex
- Male
- Age range
- from 18 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * CP/CPPS group inclusion criteria Patients are eligible for the study if they meet the following criteria: * Participant has signed and dated the appropriate Informed Consent document. * Agreed to participate in Study procedures. * Participant is at least 18 years of age. * Participant reports a response of at least 1 on the pain, pressure or discomfort scale (SYM-Q, Question #1). * Participant reports pain or discomfort in any of the 8 domains of the Male Genitourinary Pain Index (MGUPI) (items 1a, 1b, 1c, 1d, 2a, 2b, 2c, 2d). * These CP/CPPS symptoms been present for the majority of the time during any 3 months in the previous 6 months. Exclusion Criteria: * Participant has an on-going symptomatic urethral stricture. * Participant has an on-going neurological disease or disorder affecting the bladder or bowel fistula. Participant has a history of cystitis caused by tuberculosis, radiation therapy or Cytoxan/cyclophosphamide therapy. * Participant has augmentation cystoplasty or cystectomy. * Participant has a history of cancer (with the exception of skin cancer). * Participant has current major psychiatric disorder or other psychiatric or medical issues that would interfere with study participation (e.g. dementia, psychosis, upcoming major surgery, etc). * Participant diagnosed with unilateral orchialgia, without pelvic symptoms. * Participant has a history of transurethral microwave thermotherapy (TUMT), transurethral needle ablation (TUNA), balloon dilation, prostate cryo-surgery, or laser procedure. Control group exclusion criteria In addition to the exclusion criteria listed above additional criteria for control subjects are as follows. 1. In the past year, symptoms of discomfort or pain in the pelvic region for extended periods of time. 2. Volunteers who have had a urinary tract infection with a urine culture value of \>100,000 CFU/ml within the past three months. 3. Volunteers treated with intravesical chemotherapy or BCG. 4. Volunteers who have had any of the following sexually transmitted diseases (STDs) - gonorrhea, chlamydia, mycoplasma or trichomonas. 5. Volunteers with inflammatory bowel disease (such as Crohn's disease or ulcerative colitis, but not irritable bowel syndrome)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01676857